Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2013-11-13 Director's Dealing
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2013-11-13 English
PRIMARY DOCUMENT
Director's Dealing
2013-11-13 English
PRIMARY DOCUMENT
Director's Dealing
2013-11-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the completion of a merger, issuance of convertible debentures and warrants, amendments to a share incentive plan, bonuses and stock option awards to executives, and other corporate governance matters. It does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). It also is not a transcript, proxy statement, or earnings release. The primary focus is on material definitive agreements, securities issuance, and management compensation changes, which are typical disclosures in an 8-K filing. Since 8-K filings are regulatory filings reporting significant corporate events, the appropriate classification is Regulatory Filings (RNS). The document length and detail confirm it is not a brief announcement but a substantive regulatory filing. Confidence is high due to the clear identification as a Form 8-K and the nature of the content.
2013-11-13 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 11, 2013, reporting the results of the Annual Meeting of Stockholders. It details the voting outcomes on various proposals including election of directors, advisory votes on executive compensation, ratification of auditors, and approval of an amendment to the certificate of incorporation. The content is focused on the official results of shareholder votes at the Annual Meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 5502 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2013-10-16 English
PROSPECTUS SUPPLEMENT
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q QUARTERLY REPORT' and is filed pursuant to the Securities Exchange Act of 1934 for the quarterly period ended July 31, 2013. It contains detailed financial statements including balance sheets, statements of operations, shareholders' deficiency, cash flows, and notes to the financial statements. It also includes management's discussion and analysis, risk factors, legal proceedings, and other comprehensive financial information typical of a quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual quarterly report, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2013-10-02 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.